Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]
Druginjection of Lumason (ultrasound contrast agent)
Other names: Lumason
NCT Number: NCT03490929
Children with blunt abdominal trauma often get a CT as the first line imaging to evaluate for intra-abdominal organ injury. CT scans have some downsides with regard to radiation exposure, costs, and need for transport. Contrast enhanced ultrasonography has recently shown some promise as a way to detect intra-abdominal organ injury and may be able to replace the need for conventional CT scanning, without the need for ionizing radiation and the ability to be performed at the bedside.
Interested in participating?
Request Info0 year–17 year
All sexes
Interventional
Phase 4
Mayo Clinic, Rochester, Minnesota, United States
In children with abdominal trauma, computed tomography (CT) of the abdomen is considered the gold standard for the initial evaluation of solid organ injuries. The major drawbacks to CT include risks due to radiation exposure and necessity of transport of the patient. Ultrasound without contrast uses safer non-ionizing radiation and can be performed at the bedside, however it has been shown to have variable sensitivity and specificity for identifying intra-abdominal organ injury. Newer studies using contrast enhanced ultrasound (CEUS) have shown promise for improving the sensitivity and specificity of this imaging modality.
Hypothesis(es) and Aims:
Hypothesis: Contrast enhanced ultrasound (CEUS) has good sensitivity and specificity as compared to a gold standard conventional CT scan for the identification of intra-abdominal solid organ injury in hemodynamically stable children with blunt abdominal trauma. Specific Aims:
Primary Aim: To determine the test characteristics CEUS / conventional ultrasound for the detection of intra-abdominal solid organ injury, as compared to a gold standard CT scan, in hemodynamically stable children with blunt abdominal trauma
Design:
This will be a prospective cohort study to evaluate the test characteristics of contrast enhanced ultrasound (CEUS) for the detection of intra-abdominal solid organ injury in children with blunt abdominal trauma, as compared to a gold standard CT scan. Study subjects will be age 0-18 years, presenting with hemodynamically stable blunt abdominal trauma and for whom an abdominal CT scan is planned. The exclusion criteria will be a known allergy to the ultrasound contrast agent, co-existing penetrating abdominal trauma, or known congenital or acquired heart disease. Sample size calculations assume a baseline prevalence of disease in approximately 20% of patients receiving a CT scan, and target a sensitivity of at least 95% with a two-sided confidence interval precision of 8%, yielding an estimated sample size of 146 patients. The primary outcome will be calculation of sensitivity and specificity of CEUS as compared to a gold standard CT scan.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
injection of Lumason (ultrasound contrast agent)
Other names: Lumason
ultrasound of the abdomen after injection of ultrasound contrast agent (Lumason)
Other names: ultrasound
Time frame: through study completion, which is expected to take around 3 years
calculation of sensitivity of CEUS for organ injury, as compared to gold standard CT
Time frame: through study completion, which is expected to take around 3 years
calculation of specificity of CEUS for organ injury, as compared to gold standard CT exam
Contact information is provided by the study sponsor or research team.
Aaron E Chen, MD
CONTACT
Rachel Rempell, MD
CONTACT
Children's Hospital of Philadelphia
Other
Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05288985
Abdominal Injuries, Trauma Abdomen
La Roche-sur-Yon, France
View Trial DetailsNCT07314437
Abdominal Injuries, Trauma (Including Fractures)
Plymouth, Devon, United Kingdom
View Trial DetailsNCT07142876
Abdominal Injuries, Adenocarcinoma
View Trial DetailsNCT06043414
Abdominal Injuries, Dehiscence Wound
Los Angeles, California, United States
View Trial Details